BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26464214)

  • 21. E3 ubiquitin ligases in cancer and implications for therapies.
    Wang D; Ma L; Wang B; Liu J; Wei W
    Cancer Metastasis Rev; 2017 Dec; 36(4):683-702. PubMed ID: 29043469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of aberrant proteolysis in lymphomagenesis.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Curr Opin Hematol; 2015 Jul; 22(4):369-78. PubMed ID: 26049759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.
    Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
    Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UBR5 promotes cell proliferation and inhibits apoptosis in colon cancer by destablizing P21.
    Ji SQ; Zhang YX; Yang BH
    Pharmazie; 2017 Jul; 72(7):408-413. PubMed ID: 29441938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DCAF1 (VprBP): emerging physiological roles for a unique dual-service E3 ubiquitin ligase substrate receptor.
    Schabla NM; Mondal K; Swanson PC
    J Mol Cell Biol; 2019 Sep; 11(9):725-735. PubMed ID: 30590706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E3 ubiquitin ligases as cancer targets and biomarkers.
    Sun Y
    Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease.
    Dhingani N; Guo C; Pan J; Li Q; Warner N; Jardine S; Leung G; Kotlarz D; Gonzaga-Jauregui C; Klein C; Snapper SB; Navas-López VM; Muise AM
    Sci Rep; 2020 Oct; 10(1):18648. PubMed ID: 33122718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin.
    de Vivo A; Sanchez A; Yegres J; Kim J; Emly S; Kee Y
    Nucleic Acids Res; 2019 Jan; 47(2):729-746. PubMed ID: 30508113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling Pathways Regulated by UBR Box-Containing E3 Ligases.
    Kim JG; Shin HC; Seo T; Nawale L; Han G; Kim BY; Kim SJ; Cha-Molstad H
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
    Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
    Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review: targeting UBR5 domains to mediate emerging roles and mechanisms: chance or necessity?
    Wang Y; Niu K; Shi Y; Zhou F; Li X; Li Y; Chen T; Zhang Y
    Int J Surg; 2024 May; ():. PubMed ID: 38701508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets.
    Shi D; Grossman SR
    Cancer Biol Ther; 2010 Oct; 10(8):737-47. PubMed ID: 20930542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer.
    Chen C; Seth AK; Aplin AE
    Mol Cancer Res; 2006 Oct; 4(10):695-707. PubMed ID: 17050664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.
    Confalonieri S; Quarto M; Goisis G; Nuciforo P; Donzelli M; Jodice G; Pelosi G; Viale G; Pece S; Di Fiore PP
    Oncogene; 2009 Aug; 28(33):2959-68. PubMed ID: 19543318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of TGF-beta family signaling by E3 ubiquitin ligases.
    Inoue Y; Imamura T
    Cancer Sci; 2008 Nov; 99(11):2107-12. PubMed ID: 18808420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy.
    Zhang R; Liu W; Sun J; Kong Y; Chen C
    Pharmacol Res; 2020 May; 155():104748. PubMed ID: 32147403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orphan quality control shapes network dynamics and gene expression.
    Mark KG; Kolla S; Aguirre JD; Garshott DM; Schmitt S; Haakonsen DL; Xu C; Kater L; Kempf G; Martínez-González B; Akopian D; See SK; Thomä NH; Rapé M
    Cell; 2023 Aug; 186(16):3460-3475.e23. PubMed ID: 37478862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular functions of NEDD4 E3 ubiquitin ligases in cancer.
    Zou X; Levy-Cohen G; Blank M
    Biochim Biophys Acta; 2015 Aug; 1856(1):91-106. PubMed ID: 26116757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional roles of E3 ubiquitin ligases in prostate cancer.
    Zhao Y; Li J; Chen J; Ye M; Jin X
    J Mol Med (Berl); 2022 Aug; 100(8):1125-1144. PubMed ID: 35816219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.